Comparison of ATB FUNGUS 2 and VITEK-2 Antifungal Susceptibility (AST-YS01) Tests for Candida Species Isolated from Blood Culture

Soon-Deok PARK; Young UH; In-Ho JANG; Kap-Jun YOON; Jong-Hee SHIN.
Korean Journal of Clinical Microbiology ; : 114-120, 2010.
Artículo en Ko | WPRIM | ID: wpr-152158

Documentos relacionados

  1. Surveillance Study of Epidemiology, Antifungal Susceptibility and Risk Factors of Invasive Candidiasis in Critically ill Patients.
  2. Investigation of the Physiological, Biochemical and Antifungal Susceptibility Properties of Candida auris.
  3. Antifungal susceptibility profile and biofilm-producing capability of Candida tropicalis isolates in a tertiary medical centre.
  4. <i>Candida</i> meningitis/ventriculitis over a decade. Increased morbidity and length of stay a concern.
  5. Rapid Antifungal Susceptibility Testing Based on Single-Cell Metabolism Analysis Using Stimulated Raman Scattering Imaging.
  6. Categorizing Susceptibility of Clinical Isolates of <i>Candida auris</i> to Amphotericin B, Caspofungin, and Fluconazole by Use of the CLSI M44-A2 Disk Diffusion Method.
  7. <i>In Vitro</i> and <i>In Vivo</i> Antifungal Activity of AmBisome Compared to Conventional Amphotericin B and Fluconazole against Candida auris.
  8. Heightened Efficacy of Anidulafungin When Used in Combination with Manogepix or 5-Flucytosine against Candida auris <i>In Vitro</i>.
  9. Direct Fluconazole Disk Susceptibility Testing for Candida glabrata-Positive Blood Cultures.
  10. [One-Year Candida Data of the Central Mycology Laboratory: Which Sample, Which Species, How Resistant?]